| « Sudbury family hosts blood donor clinic in honour of family member ... | Human Genome Sciences Announces Fourth Quarter and Full Year 2007 ... » |
Proteolix Names Matthew Ferguson to Newly-Created Position of ...
02/26/08
Proteolix Names Matthew Ferguson to Newly-Created Position of ...
Link: http://sev.prnewswire.com/health-care-hospitals/20080225/AQM08625022008-1.html
PR Newswire (press release), NY - 16 hours ago Carfilzomib is currently in Phase II clinical studies to evaluate its safety and efficacy in multiple myeloma, lymphoma and solid tumor malignancies.
XML Feeds